- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.89 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x MYR- GLY- ALA- ASN- PHE: 4-mer lipopeptide(Non-covalent)
- 1 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 2 x ACT: ACETATE ION(Non-functional Binders)
ACT.3: 2 residues within 4Å:- Chain A: D.221, E.223
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:D.221, A:E.223
- Hydrogen bonds: A:E.223
ACT.4: 5 residues within 4Å:- Chain A: S.3, H.4, D.103, R.112
- Ligands: EDO.11
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.103, A:R.112
- 2 x ZN: ZINC ION(Non-covalent)
- 26 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.7: 9 residues within 4Å:- Chain A: G.208, A.237, D.239, T.241, F.242, Q.243
- Chain B: R.13, H.14
- Ligands: EDO.15
Ligand excluded by PLIPEDO.8: 6 residues within 4Å:- Chain A: E.213, I.214, T.215, Q.263, H.264, E.265
Ligand excluded by PLIPEDO.9: 1 residues within 4Å:- Chain A: A.91
Ligand excluded by PLIPEDO.10: 2 residues within 4Å:- Chain A: H.198
- Ligands: ZN.5
Ligand excluded by PLIPEDO.11: 4 residues within 4Å:- Chain A: S.5, D.30, D.31
- Ligands: ACT.4
Ligand excluded by PLIPEDO.12: 4 residues within 4Å:- Chain A: Y.85, M.139, A.140, I.143
Ligand excluded by PLIPEDO.13: 3 residues within 4Å:- Chain A: R.45, M.46, W.61
Ligand excluded by PLIPEDO.14: 6 residues within 4Å:- Chain A: R.7, F.9, Y.28, D.30
- Chain B: Y.64
- Ligands: EDO.16
Ligand excluded by PLIPEDO.15: 4 residues within 4Å:- Chain A: K.187, L.207, G.208
- Ligands: EDO.7
Ligand excluded by PLIPEDO.16: 7 residues within 4Å:- Chain A: Y.28, D.31, F.242
- Chain B: Y.64
- Ligands: EDO.14, EDO.29, EDO.32
Ligand excluded by PLIPEDO.17: 5 residues within 4Å:- Chain A: H.189, W.205, L.207
- Chain B: P.15
- Ligands: EDO.27
Ligand excluded by PLIPEDO.18: 3 residues within 4Å:- Chain A: D.107, G.108, R.170
Ligand excluded by PLIPEDO.19: 5 residues within 4Å:- Chain A: G.113, Y.114, L.127, K.128, E.129
Ligand excluded by PLIPEDO.20: 2 residues within 4Å:- Chain A: L.273, R.274
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain A: F.110, E.129, D.130, L.131, R.158, E.162
Ligand excluded by PLIPEDO.22: 4 residues within 4Å:- Chain A: Q.55, E.56, R.171, N.175
Ligand excluded by PLIPEDO.23: 3 residues within 4Å:- Chain A: A.159, Y.160, T.164
Ligand excluded by PLIPEDO.24: 3 residues within 4Å:- Chain A: A.150, A.151, H.152
Ligand excluded by PLIPEDO.25: 8 residues within 4Å:- Chain B: L.41, K.42, N.43, G.44, E.78, Y.79, A.80, K.95
Ligand excluded by PLIPEDO.26: 7 residues within 4Å:- Chain A: F.9, M.99, Q.116
- Chain B: F.57, S.58, K.59, W.61
Ligand excluded by PLIPEDO.27: 9 residues within 4Å:- Chain A: L.207, R.235, Q.243
- Chain B: Y.11, S.12, H.14, P.15, M.100
- Ligands: EDO.17
Ligand excluded by PLIPEDO.28: 4 residues within 4Å:- Chain A: R.22, I.24
- Chain B: S.34, D.35
Ligand excluded by PLIPEDO.29: 6 residues within 4Å:- Chain A: P.236
- Chain B: S.53, Y.64, L.66
- Ligands: EDO.16, EDO.32
Ligand excluded by PLIPEDO.30: 6 residues within 4Å:- Chain B: Q.9, V.10, V.94, K.95, W.96, D.97
Ligand excluded by PLIPEDO.31: 4 residues within 4Å:- Chain A: E.233
- Chain B: S.58, K.59, D.60
Ligand excluded by PLIPEDO.32: 6 residues within 4Å:- Chain A: P.236, F.242
- Chain B: Y.27, Y.64
- Ligands: EDO.16, EDO.29
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Asa, M. et al., Crystal structures of N-myristoylated lipopeptide-bound HLA class I complexes indicate reorganization of B-pocket architecture upon ligand binding. J.Biol.Chem. (2022)
- Release Date
- 2022-06-22
- Peptides
- MHC class I antigen: A
Beta-2-microglobulin: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.89 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x MYR- GLY- ALA- ASN- PHE: 4-mer lipopeptide(Non-covalent)
- 1 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 2 x ACT: ACETATE ION(Non-functional Binders)
- 2 x ZN: ZINC ION(Non-covalent)
- 26 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Asa, M. et al., Crystal structures of N-myristoylated lipopeptide-bound HLA class I complexes indicate reorganization of B-pocket architecture upon ligand binding. J.Biol.Chem. (2022)
- Release Date
- 2022-06-22
- Peptides
- MHC class I antigen: A
Beta-2-microglobulin: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B